Jeremy Springhorn

Jeremy P.
Springhorn currently works at Nido Biosciences, Inc., as Chief Executive Officer & Director from 2021, Juvenile Diabetes Research Foundation Canada, as Director-Fundraising & Development, uniQure NV, as Independent Non-Executive Director from 2017, NMD Pharma A, as Non-Executive Director from 2019, Biotechnology Innovation Organization, as Member-Licensing Executives Society from 2013, Colby College, as Member-Visitors Board, and Licensing Executives Society, as Member.
Dr. Springhorn also formerly worked at Protein Therapeutics, Inc., as Senior Director, Mythic Therapeutics, Inc., as Director, Alexion Pharmaceuticals, Inc., as VP-Corporate Strategy & Business Development from 2006 to 2015, Flagship Pioneering, Inc., as Partner & Head- Corporate Development from 2015 to 2017, Arradial, Inc., as Scientific Advisor, and Syros Pharmaceuticals, Inc., as Chief Business Officer from 2017 to 2021.
Dr. Springhorn received his undergraduate degree in 1984 from Colby College and doctorate degree in 1989 from Louisiana State University.